Skip to contentPALEKAR ROHAN — 89bio, Inc. insider: 114 transactions · InsiderLensPALEKAR ROHAN
- Director at Neurogene Inc. · on record since Jan 18, 2024
- Chief Commercial Officer at MEDIVATION, INC. · on record since Jan 16, 2008
- SVP & Chief Commercial Officer at AVANIR PHARMACEUTICALS · on record since Mar 26, 2012
- SVP & Chief Commercial Officer at AVANIR PHARMACEUTICALS · on record since Dec 19, 2012
- Director at 89bio, Inc. · on record since Nov 8, 2019
- Chief Executive Officer at 89bio, Inc. · on record since Nov 8, 2019
- Director at SMI PRODUCTS INC · on record since Mar 4, 2022
Insider trading activity of PALEKAR ROHAN
- Transactions on record
- 114
- since Jan 16, 2008
- Open-market buys
- 9
- $388.2K
- Open-market sells
- 17
- $4.4M
- Companies traded
- 5
- last filing Feb 24, 2026
Figures computed from official regulatory filings — methodology.
Companies where PALEKAR ROHAN has traded
Track record of PALEKAR ROHAN
Statistical track record
Free- Open-market buys
- 9
- Last buy
- Dec 6, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of PALEKAR ROHAN
Co-insiders of PALEKAR ROHAN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Nolan Sean P.Neurogene Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 24, 2026 | AwardD | 12,050 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -220,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -132,242 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -170,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -203,750 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -848,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -300,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | Other | -934,273 | — | — | SEC |
| Oct 30, 2025 | OtherD | -605,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -120,231 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | Award | 125,000 | 0.00 USD | $0 | SEC |
| Aug 5, 2025 | Other | -55,836 | 9.16 USD | $511.5K | SEC |
| Jun 13, 2025 | AwardD | 12,050 | 0.00 USD | $0 | SEC |
| Feb 19, 2025 | Other | -3,249 | 10.57 USD | $34.3K | SEC |
| Feb 11, 2025 | Other | -8,946 | 11.41 USD | $102.1K | SEC |
| Feb 4, 2025 | AwardD | 848,000 | 0.00 USD | $0 | SEC |
| Feb 4, 2025 | Other | -9,598 | 9.60 USD | $92.1K | SEC |
| Feb 4, 2025 | Award | 212,000 | 0.00 USD | $0 | SEC |
| Feb 4, 2025 | Award | 200,000 | 0.00 USD | $0 | SEC |
| Dec 10, 2024 | Buy | 5,000 | 7.89 USD | $39.5K | SEC |
| Nov 25, 2024 | Buy | 10,000 | 8.35 USD | $83.5K | SEC |
| Aug 19, 2024 | Other | -4,601 | 8.04 USD | $37K | SEC |
| Jun 17, 2024 | AwardD | 7,700 | 0.00 USD | $0 | SEC |
| Apr 3, 2024 | Exercise | 25,000 | 1.93 USD | $48.3K | SEC |
| Apr 3, 2024 | ExerciseD | -25,000 | 0.00 USD | $0 | SEC |